148 related articles for article (PubMed ID: 12066790)
41. Metformin in polycystic ovary syndrome.
Raskauskas TA
N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18434659
[No Abstract] [Full Text] [Related]
42. Metformin in obstetric and gynecologic practice: a review.
McCarthy EA; Walker SP; McLachlan K; Boyle J; Permezel M
Obstet Gynecol Surv; 2004 Feb; 59(2):118-27. PubMed ID: 14752300
[TBL] [Abstract][Full Text] [Related]
43. What is the best first-step therapeutic approach in treating anovulatory infertility in patients with polycystic ovary syndrome? Questions that are still unanswered.
Palomba S; Orio F; Zullo F
Gynecol Endocrinol; 2007 May; 23(5):245-7. PubMed ID: 17558680
[No Abstract] [Full Text] [Related]
44. Metformin use and diabetic pregnancy-has its time come?
Hawthorne G
Diabet Med; 2006 Mar; 23(3):223-7. PubMed ID: 16492202
[TBL] [Abstract][Full Text] [Related]
45. Insulin-sensitizing agents in women with polycystic ovary syndrome.
Pasquali R; Gambineri A
Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
[TBL] [Abstract][Full Text] [Related]
46. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
47. The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome.
Malkawi HY; Qublan HS
Saudi Med J; 2002 Jun; 23(6):663-6. PubMed ID: 12070543
[TBL] [Abstract][Full Text] [Related]
48. Metformin and polycystic ovary syndrome.
Lebinger TG
Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
[TBL] [Abstract][Full Text] [Related]
49. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
[TBL] [Abstract][Full Text] [Related]
50. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
51. Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation.
Vanky E; Salvesen KA; Hjorth-Hansen H; Bjerve K; Carlsen SM
Fertil Steril; 2006 Mar; 85(3):770-4. PubMed ID: 16500361
[TBL] [Abstract][Full Text] [Related]
52. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
[TBL] [Abstract][Full Text] [Related]
53. Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome.
Hutchison SK; Zoungas S; Teede HJ
Med J Aust; 2007 Mar; 186(5):268-9; author reply 271-2. PubMed ID: 17391092
[No Abstract] [Full Text] [Related]
54. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
Kriplani A; Agarwal N
J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
[TBL] [Abstract][Full Text] [Related]
55. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
[TBL] [Abstract][Full Text] [Related]
56. Metformin.
Nurs Times; 2005 Oct 4-10; 101(40):37-8. PubMed ID: 16250540
[No Abstract] [Full Text] [Related]
57. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
58. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
59. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
[TBL] [Abstract][Full Text] [Related]
60. Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial.
Qublan HS; Al-Khaderei S; Abu-Salem AN; Al-Zpoon A; Al-Khateeb M; Al-Ibrahim N; Megdadi M; Al-Ahmad N
J Obstet Gynaecol; 2009 Oct; 29(7):651-5. PubMed ID: 19757275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
